Supra-aortic interventions for endovascular exclusion of the entire aortic arch

Abstract Objective Our aim was to analyze the outcomes of endovascular exclusion of the entire aortic arch (proximal landing in zone 0, distal landing in zone III or beyond, after Ishimaru) in which complete surgical debranching of the supra-aortic vessels (I), endovascular supra-aortic revasculariz...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of vascular surgery 2017-07, Vol.66 (1), p.281-297.e2
Hauptverfasser: Andrási, Terézia B., MD, PhD, Grossmann, Marius, MD, Zenker, Dieter, MD, Danner, Bernhard C., MD, PhD, Schöndube, Friedrich A., MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 297.e2
container_issue 1
container_start_page 281
container_title Journal of vascular surgery
container_volume 66
creator Andrási, Terézia B., MD, PhD
Grossmann, Marius, MD
Zenker, Dieter, MD
Danner, Bernhard C., MD, PhD
Schöndube, Friedrich A., MD, PhD
description Abstract Objective Our aim was to analyze the outcomes of endovascular exclusion of the entire aortic arch (proximal landing in zone 0, distal landing in zone III or beyond, after Ishimaru) in which complete surgical debranching of the supra-aortic vessels (I), endovascular supra-aortic revascularization (chimney, fenestrated, or branched grafts) with partial surgical debranching (II), or total endovascular supra-aortic revascularization (III) was additionally performed. Methods Publications describing endovascular repair of the aortic arch (2000-2016) were systematically searched and reviewed. Results From a total of 53 relevant studies including 1853 patients, only 1021 patients undergoing 35 different total aortic arch procedures were found eligible for further evaluation and included in group I, II, or III (429, 190, and 402 patients, respectively). Overall early mortality was higher in group I vs groups II and III ( P  = .001; 1 − β = 95.6%) but exceeded in group III (18.6%) and group II (14.0%) vs group I (8.0%; P  = .044; 1 − β = 57.4%) for diseases involving zone 0. Mortality was higher in all subgroups treated for zone 0 disease compared with corresponding subgroups treated for zone I to zone III disease. The incidence of cerebral ischemic events was increased in groups I and II vs group III (7.5% and 11% vs 1.7%; P  = .0001) and correlated with early mortality ( R2  = .20; P  = .033). The incidence of type II endoleaks and endovascular reintervention was similar between groups and correlated with each other ( R2  = .37; P  = .004). Type Ia endoleak occurred more often in groups II and III than in group I (7.1% and 12.1% vs 5.8%; P  = .023) and correlated with midterm mortality ( R2  = .53; P  = .005). Retrograde type A dissection was low in all groups, whereas aneurysm growth was higher in group III (2.6%, 4.2%, 10.7%; P  = .002), correlating with midterm mortality ( R2  = .311; P  = .009). Surgical revision slightly correlated with surgical complications ( R2  = .18; P  = .044) but not with mortality ( R2  = .10; P  = .214). Conclusions Because early mortality was significantly higher in patients receiving endovascular treatment for proximal aortic disease, endovascular-based approaches proved to be feasible alternatives to hybrid surgical procedures, especially when they were performed for aneurysms located in the distal aortic arch. Whereas cerebral ischemia accompanies both surgical and endovascular involvement of the supra-aortic vessels, en
doi_str_mv 10.1016/j.jvs.2017.04.024
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1913831154</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521417311035</els_id><sourcerecordid>1913831154</sourcerecordid><originalsourceid>FETCH-LOGICAL-c517t-366cc2c1756d5fff6d7798dcb582f32be45f6b13f7ae4f32f9b0dc19492e54ac3</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS0EotvCB-CCcuSS4PHfREhIqAKKVKmHwtlynLHqkI0XO1m13x5Hu3DgwGnk8XtPer8h5A3QBiio92MzHnPDKOiGioYy8YzsgHa6Vi3tnpMd1QJqyUBckMucR0oBZKtfkgvWKqEpVztyd78ekq1tTEtwVZgXTEeclxDnXPmYKpyHeLTZrZMtj0c3rbn8VdFXywNWmzJhdXbb5B5ekRfeThlfn-cV-fHl8_frm_r27uu360-3tZOgl5or5RxzoKUapPdeDVp37eB62TLPWY9CetUD99qiKAvf9XRw0ImOoRTW8Svy7pR7SPHXinkx-5AdTpOdMa7ZQAe85aWvKFI4SV2KOSf05pDC3qYnA9RsHM1oCkezcTRUmMKxeN6e49d-j8Nfxx9wRfDhJMBS8hgwmewCzg6HAsQtZojhv_Ef_3G7KczB2eknPmEe45rmQs-AycxQc78dcrsj6FKJcsl_A2YQmU0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1913831154</pqid></control><display><type>article</type><title>Supra-aortic interventions for endovascular exclusion of the entire aortic arch</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Andrási, Terézia B., MD, PhD ; Grossmann, Marius, MD ; Zenker, Dieter, MD ; Danner, Bernhard C., MD, PhD ; Schöndube, Friedrich A., MD, PhD</creator><creatorcontrib>Andrási, Terézia B., MD, PhD ; Grossmann, Marius, MD ; Zenker, Dieter, MD ; Danner, Bernhard C., MD, PhD ; Schöndube, Friedrich A., MD, PhD</creatorcontrib><description>Abstract Objective Our aim was to analyze the outcomes of endovascular exclusion of the entire aortic arch (proximal landing in zone 0, distal landing in zone III or beyond, after Ishimaru) in which complete surgical debranching of the supra-aortic vessels (I), endovascular supra-aortic revascularization (chimney, fenestrated, or branched grafts) with partial surgical debranching (II), or total endovascular supra-aortic revascularization (III) was additionally performed. Methods Publications describing endovascular repair of the aortic arch (2000-2016) were systematically searched and reviewed. Results From a total of 53 relevant studies including 1853 patients, only 1021 patients undergoing 35 different total aortic arch procedures were found eligible for further evaluation and included in group I, II, or III (429, 190, and 402 patients, respectively). Overall early mortality was higher in group I vs groups II and III ( P  = .001; 1 − β = 95.6%) but exceeded in group III (18.6%) and group II (14.0%) vs group I (8.0%; P  = .044; 1 − β = 57.4%) for diseases involving zone 0. Mortality was higher in all subgroups treated for zone 0 disease compared with corresponding subgroups treated for zone I to zone III disease. The incidence of cerebral ischemic events was increased in groups I and II vs group III (7.5% and 11% vs 1.7%; P  = .0001) and correlated with early mortality ( R2  = .20; P  = .033). The incidence of type II endoleaks and endovascular reintervention was similar between groups and correlated with each other ( R2  = .37; P  = .004). Type Ia endoleak occurred more often in groups II and III than in group I (7.1% and 12.1% vs 5.8%; P  = .023) and correlated with midterm mortality ( R2  = .53; P  = .005). Retrograde type A dissection was low in all groups, whereas aneurysm growth was higher in group III (2.6%, 4.2%, 10.7%; P  = .002), correlating with midterm mortality ( R2  = .311; P  = .009). Surgical revision slightly correlated with surgical complications ( R2  = .18; P  = .044) but not with mortality ( R2  = .10; P  = .214). Conclusions Because early mortality was significantly higher in patients receiving endovascular treatment for proximal aortic disease, endovascular-based approaches proved to be feasible alternatives to hybrid surgical procedures, especially when they were performed for aneurysms located in the distal aortic arch. Whereas cerebral ischemia accompanies both surgical and endovascular involvement of the supra-aortic vessels, endoleaks and aneurysm growth remain hallmarks of endovascular supra-aortic repair. Because surgical revision had no impact on mortality, complete surgical debranching may become the option of choice for patients with good life expectancy suffering from proximal aortic arch disease, whereas total endovascular procedures could be particularly advantageous in patients with short life expectancy and distal aortic arch disease.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2017.04.024</identifier><identifier>PMID: 28647036</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Aged, 80 and over ; Aorta, Thoracic - diagnostic imaging ; Aorta, Thoracic - surgery ; Blood Vessel Prosthesis ; Blood Vessel Prosthesis Implantation - adverse effects ; Blood Vessel Prosthesis Implantation - instrumentation ; Blood Vessel Prosthesis Implantation - methods ; Blood Vessel Prosthesis Implantation - mortality ; Endoleak - etiology ; Endovascular Procedures - adverse effects ; Endovascular Procedures - instrumentation ; Endovascular Procedures - methods ; Endovascular Procedures - mortality ; Female ; Humans ; Male ; Middle Aged ; Patient Selection ; Prosthesis Design ; Risk Factors ; Stents ; Surgery ; Time Factors ; Treatment Outcome</subject><ispartof>Journal of vascular surgery, 2017-07, Vol.66 (1), p.281-297.e2</ispartof><rights>Society for Vascular Surgery</rights><rights>2017 Society for Vascular Surgery</rights><rights>Copyright © 2017 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c517t-366cc2c1756d5fff6d7798dcb582f32be45f6b13f7ae4f32f9b0dc19492e54ac3</citedby><cites>FETCH-LOGICAL-c517t-366cc2c1756d5fff6d7798dcb582f32be45f6b13f7ae4f32f9b0dc19492e54ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0741521417311035$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28647036$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Andrási, Terézia B., MD, PhD</creatorcontrib><creatorcontrib>Grossmann, Marius, MD</creatorcontrib><creatorcontrib>Zenker, Dieter, MD</creatorcontrib><creatorcontrib>Danner, Bernhard C., MD, PhD</creatorcontrib><creatorcontrib>Schöndube, Friedrich A., MD, PhD</creatorcontrib><title>Supra-aortic interventions for endovascular exclusion of the entire aortic arch</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Abstract Objective Our aim was to analyze the outcomes of endovascular exclusion of the entire aortic arch (proximal landing in zone 0, distal landing in zone III or beyond, after Ishimaru) in which complete surgical debranching of the supra-aortic vessels (I), endovascular supra-aortic revascularization (chimney, fenestrated, or branched grafts) with partial surgical debranching (II), or total endovascular supra-aortic revascularization (III) was additionally performed. Methods Publications describing endovascular repair of the aortic arch (2000-2016) were systematically searched and reviewed. Results From a total of 53 relevant studies including 1853 patients, only 1021 patients undergoing 35 different total aortic arch procedures were found eligible for further evaluation and included in group I, II, or III (429, 190, and 402 patients, respectively). Overall early mortality was higher in group I vs groups II and III ( P  = .001; 1 − β = 95.6%) but exceeded in group III (18.6%) and group II (14.0%) vs group I (8.0%; P  = .044; 1 − β = 57.4%) for diseases involving zone 0. Mortality was higher in all subgroups treated for zone 0 disease compared with corresponding subgroups treated for zone I to zone III disease. The incidence of cerebral ischemic events was increased in groups I and II vs group III (7.5% and 11% vs 1.7%; P  = .0001) and correlated with early mortality ( R2  = .20; P  = .033). The incidence of type II endoleaks and endovascular reintervention was similar between groups and correlated with each other ( R2  = .37; P  = .004). Type Ia endoleak occurred more often in groups II and III than in group I (7.1% and 12.1% vs 5.8%; P  = .023) and correlated with midterm mortality ( R2  = .53; P  = .005). Retrograde type A dissection was low in all groups, whereas aneurysm growth was higher in group III (2.6%, 4.2%, 10.7%; P  = .002), correlating with midterm mortality ( R2  = .311; P  = .009). Surgical revision slightly correlated with surgical complications ( R2  = .18; P  = .044) but not with mortality ( R2  = .10; P  = .214). Conclusions Because early mortality was significantly higher in patients receiving endovascular treatment for proximal aortic disease, endovascular-based approaches proved to be feasible alternatives to hybrid surgical procedures, especially when they were performed for aneurysms located in the distal aortic arch. Whereas cerebral ischemia accompanies both surgical and endovascular involvement of the supra-aortic vessels, endoleaks and aneurysm growth remain hallmarks of endovascular supra-aortic repair. Because surgical revision had no impact on mortality, complete surgical debranching may become the option of choice for patients with good life expectancy suffering from proximal aortic arch disease, whereas total endovascular procedures could be particularly advantageous in patients with short life expectancy and distal aortic arch disease.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aorta, Thoracic - diagnostic imaging</subject><subject>Aorta, Thoracic - surgery</subject><subject>Blood Vessel Prosthesis</subject><subject>Blood Vessel Prosthesis Implantation - adverse effects</subject><subject>Blood Vessel Prosthesis Implantation - instrumentation</subject><subject>Blood Vessel Prosthesis Implantation - methods</subject><subject>Blood Vessel Prosthesis Implantation - mortality</subject><subject>Endoleak - etiology</subject><subject>Endovascular Procedures - adverse effects</subject><subject>Endovascular Procedures - instrumentation</subject><subject>Endovascular Procedures - methods</subject><subject>Endovascular Procedures - mortality</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patient Selection</subject><subject>Prosthesis Design</subject><subject>Risk Factors</subject><subject>Stents</subject><subject>Surgery</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9v1DAQxS0EotvCB-CCcuSS4PHfREhIqAKKVKmHwtlynLHqkI0XO1m13x5Hu3DgwGnk8XtPer8h5A3QBiio92MzHnPDKOiGioYy8YzsgHa6Vi3tnpMd1QJqyUBckMucR0oBZKtfkgvWKqEpVztyd78ekq1tTEtwVZgXTEeclxDnXPmYKpyHeLTZrZMtj0c3rbn8VdFXywNWmzJhdXbb5B5ekRfeThlfn-cV-fHl8_frm_r27uu360-3tZOgl5or5RxzoKUapPdeDVp37eB62TLPWY9CetUD99qiKAvf9XRw0ImOoRTW8Svy7pR7SPHXinkx-5AdTpOdMa7ZQAe85aWvKFI4SV2KOSf05pDC3qYnA9RsHM1oCkezcTRUmMKxeN6e49d-j8Nfxx9wRfDhJMBS8hgwmewCzg6HAsQtZojhv_Ef_3G7KczB2eknPmEe45rmQs-AycxQc78dcrsj6FKJcsl_A2YQmU0</recordid><startdate>20170701</startdate><enddate>20170701</enddate><creator>Andrási, Terézia B., MD, PhD</creator><creator>Grossmann, Marius, MD</creator><creator>Zenker, Dieter, MD</creator><creator>Danner, Bernhard C., MD, PhD</creator><creator>Schöndube, Friedrich A., MD, PhD</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170701</creationdate><title>Supra-aortic interventions for endovascular exclusion of the entire aortic arch</title><author>Andrási, Terézia B., MD, PhD ; Grossmann, Marius, MD ; Zenker, Dieter, MD ; Danner, Bernhard C., MD, PhD ; Schöndube, Friedrich A., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c517t-366cc2c1756d5fff6d7798dcb582f32be45f6b13f7ae4f32f9b0dc19492e54ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aorta, Thoracic - diagnostic imaging</topic><topic>Aorta, Thoracic - surgery</topic><topic>Blood Vessel Prosthesis</topic><topic>Blood Vessel Prosthesis Implantation - adverse effects</topic><topic>Blood Vessel Prosthesis Implantation - instrumentation</topic><topic>Blood Vessel Prosthesis Implantation - methods</topic><topic>Blood Vessel Prosthesis Implantation - mortality</topic><topic>Endoleak - etiology</topic><topic>Endovascular Procedures - adverse effects</topic><topic>Endovascular Procedures - instrumentation</topic><topic>Endovascular Procedures - methods</topic><topic>Endovascular Procedures - mortality</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patient Selection</topic><topic>Prosthesis Design</topic><topic>Risk Factors</topic><topic>Stents</topic><topic>Surgery</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andrási, Terézia B., MD, PhD</creatorcontrib><creatorcontrib>Grossmann, Marius, MD</creatorcontrib><creatorcontrib>Zenker, Dieter, MD</creatorcontrib><creatorcontrib>Danner, Bernhard C., MD, PhD</creatorcontrib><creatorcontrib>Schöndube, Friedrich A., MD, PhD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andrási, Terézia B., MD, PhD</au><au>Grossmann, Marius, MD</au><au>Zenker, Dieter, MD</au><au>Danner, Bernhard C., MD, PhD</au><au>Schöndube, Friedrich A., MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Supra-aortic interventions for endovascular exclusion of the entire aortic arch</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2017-07-01</date><risdate>2017</risdate><volume>66</volume><issue>1</issue><spage>281</spage><epage>297.e2</epage><pages>281-297.e2</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><abstract>Abstract Objective Our aim was to analyze the outcomes of endovascular exclusion of the entire aortic arch (proximal landing in zone 0, distal landing in zone III or beyond, after Ishimaru) in which complete surgical debranching of the supra-aortic vessels (I), endovascular supra-aortic revascularization (chimney, fenestrated, or branched grafts) with partial surgical debranching (II), or total endovascular supra-aortic revascularization (III) was additionally performed. Methods Publications describing endovascular repair of the aortic arch (2000-2016) were systematically searched and reviewed. Results From a total of 53 relevant studies including 1853 patients, only 1021 patients undergoing 35 different total aortic arch procedures were found eligible for further evaluation and included in group I, II, or III (429, 190, and 402 patients, respectively). Overall early mortality was higher in group I vs groups II and III ( P  = .001; 1 − β = 95.6%) but exceeded in group III (18.6%) and group II (14.0%) vs group I (8.0%; P  = .044; 1 − β = 57.4%) for diseases involving zone 0. Mortality was higher in all subgroups treated for zone 0 disease compared with corresponding subgroups treated for zone I to zone III disease. The incidence of cerebral ischemic events was increased in groups I and II vs group III (7.5% and 11% vs 1.7%; P  = .0001) and correlated with early mortality ( R2  = .20; P  = .033). The incidence of type II endoleaks and endovascular reintervention was similar between groups and correlated with each other ( R2  = .37; P  = .004). Type Ia endoleak occurred more often in groups II and III than in group I (7.1% and 12.1% vs 5.8%; P  = .023) and correlated with midterm mortality ( R2  = .53; P  = .005). Retrograde type A dissection was low in all groups, whereas aneurysm growth was higher in group III (2.6%, 4.2%, 10.7%; P  = .002), correlating with midterm mortality ( R2  = .311; P  = .009). Surgical revision slightly correlated with surgical complications ( R2  = .18; P  = .044) but not with mortality ( R2  = .10; P  = .214). Conclusions Because early mortality was significantly higher in patients receiving endovascular treatment for proximal aortic disease, endovascular-based approaches proved to be feasible alternatives to hybrid surgical procedures, especially when they were performed for aneurysms located in the distal aortic arch. Whereas cerebral ischemia accompanies both surgical and endovascular involvement of the supra-aortic vessels, endoleaks and aneurysm growth remain hallmarks of endovascular supra-aortic repair. Because surgical revision had no impact on mortality, complete surgical debranching may become the option of choice for patients with good life expectancy suffering from proximal aortic arch disease, whereas total endovascular procedures could be particularly advantageous in patients with short life expectancy and distal aortic arch disease.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28647036</pmid><doi>10.1016/j.jvs.2017.04.024</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5214
ispartof Journal of vascular surgery, 2017-07, Vol.66 (1), p.281-297.e2
issn 0741-5214
1097-6809
language eng
recordid cdi_proquest_miscellaneous_1913831154
source MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals
subjects Aged
Aged, 80 and over
Aorta, Thoracic - diagnostic imaging
Aorta, Thoracic - surgery
Blood Vessel Prosthesis
Blood Vessel Prosthesis Implantation - adverse effects
Blood Vessel Prosthesis Implantation - instrumentation
Blood Vessel Prosthesis Implantation - methods
Blood Vessel Prosthesis Implantation - mortality
Endoleak - etiology
Endovascular Procedures - adverse effects
Endovascular Procedures - instrumentation
Endovascular Procedures - methods
Endovascular Procedures - mortality
Female
Humans
Male
Middle Aged
Patient Selection
Prosthesis Design
Risk Factors
Stents
Surgery
Time Factors
Treatment Outcome
title Supra-aortic interventions for endovascular exclusion of the entire aortic arch
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T13%3A18%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Supra-aortic%20interventions%20for%20endovascular%20exclusion%20of%20the%20entire%20aortic%20arch&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Andr%C3%A1si,%20Ter%C3%A9zia%20B.,%20MD,%20PhD&rft.date=2017-07-01&rft.volume=66&rft.issue=1&rft.spage=281&rft.epage=297.e2&rft.pages=281-297.e2&rft.issn=0741-5214&rft.eissn=1097-6809&rft_id=info:doi/10.1016/j.jvs.2017.04.024&rft_dat=%3Cproquest_cross%3E1913831154%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1913831154&rft_id=info:pmid/28647036&rft_els_id=S0741521417311035&rfr_iscdi=true